Laplanche J L
Laboratoire de biologie cellulaire, UER des Sciences pharmaceutiques et biologiques, Paris.
Ann Biol Clin (Paris). 1997 Sep-Oct;55(5):395-407.
Human and animal prion diseases are rare and fatal transmissible neurodegenerative disorders and correspond to a new host-agent interaction. So far, no infectious conventional agent has been isolated from brains of affected. These diseases are characterized by the accumulation in the central nervous system of an abnormal form of the prion protein (PrPc) which is a normal cell component. This abnormal form, PrPSc or PrPres, exhibiting a very high resistance to proteases, results from a conformational change of PrPc and would be an essential part of the transmissible agent, called prion, according to the concept developed by Prusiner since 1982. PrPc is expressed at the cell surface of neurons and peripheral tissues. All mammals studied so far encode PrP. Its tertiary structure has been recently established in part by nuclear magnetic resonance. Although its physiological role is still unknown, PrPc appears to be the receptor of the contaminating agent. Mice devoid of PrP have a normal development and behaviour but are resistant to the disease. Transgenic studies have demonstrated that the molecular basis of the host susceptibility is based in part on the primary structure of PrP. In mouse, sheep and human, different amino acid substitutions in the protein have been associated with opposite incubation times. The propagation of prions would result of a conformational imprinting imposed by infectious PrePres to host PrPc. The newly acquired conformation of the host protein would transmit to all neosynthetized PrPc in a autocatalytic process. Recently, evidence for the existence of different possible conformations of the abnormal protein could explain the variability of the agent strains. Recent data indicate that prion diseases would be the first transmissible disorders in which the information carried by the agent would be hidden in the tertiary structure of a protein and not in a nucleic acid. However, the virus hypothesis has not been totally discarded by some investigators.
人类和动物的朊病毒疾病是罕见的致命性传染性神经退行性疾病,代表了一种新的宿主 - 病原体相互作用。到目前为止,尚未从患病动物的大脑中分离出具有传染性的传统病原体。这些疾病的特征是在中枢神经系统中积累一种异常形式的朊病毒蛋白(PrPc),它是一种正常的细胞成分。这种异常形式,即PrPSc或PrPres,对蛋白酶具有很高的抗性,是由PrPc的构象变化产生的,根据普鲁辛纳自1982年提出的概念,它将是传染性病原体(称为朊病毒)的重要组成部分。PrPc在神经元和外周组织的细胞表面表达。到目前为止,所有研究过的哺乳动物都编码PrP。其三级结构最近部分通过核磁共振确定。尽管其生理作用仍然未知,但PrPc似乎是污染因子的受体。缺乏PrP的小鼠发育和行为正常,但对该病具有抗性。转基因研究表明,宿主易感性的分子基础部分基于PrP的一级结构。在小鼠、绵羊和人类中,该蛋白中不同的氨基酸取代与相反的潜伏期相关。朊病毒的传播将是由传染性PrPres对宿主PrPc施加的构象印记的结果。宿主蛋白新获得的构象将在一个自催化过程中传递给所有新合成的PrPc。最近,异常蛋白存在不同可能构象的证据可以解释病原体毒株的变异性。最近的数据表明,朊病毒疾病将是第一种传染性疾病,其中病原体携带的信息隐藏在蛋白质的三级结构中,而不是核酸中。然而,一些研究人员尚未完全摒弃病毒假说。